Figure 3.
Individual disease and treatment course after Cy2 according to FLT3-ITD MRD status. (A) Course of events for the 111 patients who were FLT3-ITD MRD negative after Cy2 and (B) for the 31 patients who were FLT3-ITD MRD positive after Cy2. (C) Course of events for the 22 patients who were FLT3-ITD MRD positive during FU.